| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹1000 |
| Expense Ratio | 0.57% |
| NAV | ₹61.04 (03 Aug 2020) |
|---|---|
| Fund Started | 07 Jan 2013 |
| Fund Size | ₹11 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 9.4% |
| Bharti Airtel Ltd. | Communication | Equity | 7.7% |
| Aarti Industries Ltd. | Chemicals | Equity | 7.6% |
| Godrej Agrovet Ltd. | FMCG | Equity | 5.3% |
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 4.8% |
| Vinati Organics Ltd. | Chemicals | Equity | 4.5% |
| Sumitomo Chemical India Pvt. Ltd. | Others | Equity | 4.4% |
| Indian Railway Catering & Tourism Corpn. Ltd. | Services | Equity | 4.3% |
| Coromandel International Ltd. | Chemicals | Equity | 4.1% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 4.1% |
Quant Mid Cap Fund Direct Growth is a Hybrid Mutual Fund Scheme launched by Quant Mutual Fund. This scheme was made available to investors on 07 Jan 2013. Sanjeev Sharma is the Current Fund Manager of Quant Mid Cap Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹11 Cr and the Latest NAV as of 03 Aug 2020 is ₹61.04.
The Quant Mid Cap Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 year
To generate long term capital appreciation by predominantly moving investments in a portfolio of equity and equity related securities
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.